Recent Articles

• 
  AI Healthcare

  Daewoong Pharma Adds AI to Endoscopy for GI Care

  Daewoong Pharmaceutical CEO Chang-jae Lee (right) and Weisen CEO Kyung-nam Kim pose for a commemorative photo after signing the agreement. Provided by Daewoong Pharmaceutical Daewoong Pharmaceutical is entering the AI endoscopic image analysis software market through a partnership with medical artif

  2026.07.10
• 
  K-Beauty

  Inner Beauty Rides GLP-1 Wave as K-Beauty Growth Driver

  Products are displayed at CJ Olive Young’s first U.S. store, which opened on May 29 (local time) in Pasadena, California. Photo=Getty Images The inner beauty segment, often referred to as “ingestible cosmetics” in the global beauty market, is emerging as a new growth axis. As the popularity of GLP-1

  2026.07.09
• 
  AI Healthcare

  Wearable Patch Shows Brain ‘Cleaning’ During Sleep

  A graphic visualizing real-time monitoring of the brain’s waste clearance (“brain cleaning”) process and physiological changes during comfortable sleep at home using a wireless wearable sensor attached to the forehead. Image created with the generative AI Gemini. While a person sleeps, the brain car

  2026.07.09
• 
  Biopharma

  SCL Science Wins Code, Begins Supplying Hemostats

  SCL Science announced on the 8th that its independently developed Grade 4 bioabsorbable hemostatic agent “InnoSEAL Plus DL” has recently obtained a treatment material code from Seoul St. Mary’s Hospital of The Catholic University of Korea and that the initial shipment has been completed.The treatmen

  2026.07.08
• 
  Global Business

  GC Wellbeing Targets Japan Aesthetic Medicine Market

  GC 녹십자웰빙 is introducing its aesthetic products while operating a joint promotional booth with its local partner at the “ASLS TOKYO 2026,” the Japan academic conference of the Korean Academy of Aesthetic Surgery & Laser, held in Tokyo, Japan. Provided by GC녹십자웰빙 GC녹십자웰빙 has entered the Japanese marke

  2026.07.07
• 
  Medi-Expo

  Daegu Medi-Expo Secures KRW 168.3 Billion Deals

  The largest healthcare industry trade exhibition held outside the Seoul metropolitan area, which took place in Daegu, achieved export consultation results amounting to approximately USD 110 million (about KRW 168.3 billion), confirming the global competitiveness of the regional medical industry.Daeg

  2026.07.07
• 
  Drug Development

  Huons Begins Phase 2 Trial of Dry Eye Drug

  Huons has begun full-fledged Phase 2 clinical trials of “HUC1-394,” a peptide-based new drug candidate for the treatment of dry eye disease. Provided by Huons Huons has begun full-fledged Phase 2 clinical trials of “HUC1-394,” a peptide-based new drug candidate for the treatment of dry eye disease.

  2026.07.06
• 
  Biotech

  KAERI Extracts Lawn Anti-Hair Loss Compound for Products

  The Korea Atomic Energy Research Institute (KAERI) announced on the 5th that a functional cosmetic product to alleviate hair loss symptoms, using as its main ingredient a natural material extracted from centipedegrass, a type of turfgrass, has finally passed the Ministry of Food and Drug Safety revi

  2026.07.06
• 
  Bioprocessing / CDMO

  Lotte Chairman Shin Targets Global Bio Contracts

  On July 3, Lotte Group Chairman Shin Dong-bin visited Plant 1 of the Lotte Biologics Songdo Campus, located in Yeonsu-gu, Incheon, to conduct on-site management. Chairman Shin (second from left) is being briefed on the production process in front of a 15,000-liter bioreactor in the plant’s productio

  2026.07.05
• 
  Celltrion

  Celltrion Q2 Margin 33%, Growth Back on Track

  Celltrion announced on the 3rd that on a consolidated basis for the second quarter of this year, it posted provisional results of KRW 1.3 trillion in revenue and KRW 430 billion in operating profit. Compared with the same period last year, revenue increased 35.2% and operating profit 77.3%, reflecti

  2026.07.03